Because PCOS is associated with enhanced WAT lipolysis (161), and WAT-derived SAA also augments lipolysis (9), we speculate that WAT-derived SAA may play a causal role in PCOS-mediated metabolic dysfunction. This evidence concerns the gene SAA2 and polycystic ovary syndrome.